ARTICLE | Management Tracks
Management changes at Astellas
Plus: Lundbeck board planning to elect Dorothea Wenzel chair, and updates from PacBio and Uvax Bio
February 5, 2025 1:35 AM UTC
Astellas Pharma Inc. (Tokyo:4503) is changing its management structure effective April 1, replacing its CMO, chief commercial officer (CCO) and CSO positions with newly created roles.
CMO Tadaaki Taniguchi and CCO Claus Zieler will become chief R&D officer and chief commercial and medical affairs officer, respectively. CSO Yoshitsugu Shitaka is set to resign effective March 31. ...